Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

SHA/600671 stock hub

SHA/600671 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHA/600671is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.4B
Shanghai Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHA/600671
In the news

Latest news · SHA/600671

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E149.6
P25 23.5P50 41.3P75 83.2
ROE8
P25 -0.9P50 4.1P75 8.8
ROIC4.3
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHA/600671 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
210
Groups with data
11
Currency
CNY
Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
362
Employees Change
-18%
Employees Change Percent
-4.74
Enterprise value
CNY 2.6B
Exchange
Shanghai Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - General
Isin
CNE000000BF3
Last refreshed
2026-05-10
Market cap
CNY 2.4B
Price
CNY 20.08
Price currency
CNY
Rev Per Employee
563,118.42x
Sector
Healthcare
Sic
2834
Symbol
sha/600671
Website
https://www.hztmyy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
0.67%
EV Earnings
159.7x
EV/EBIT
136.22x
EV/EBITDA
75.8x
EV/FCF
-92.99x
EV/Sales
12.8x
FCF yield
-1.15%
P/B ratio
25.19x
P/E ratio
149.64x
P/S ratio
12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
7.8%
EBITDA Margin
15.22%
Gross margin
50.55%
Gross Profit
CNY 103.1M
Gross Profit Growth
-9.32%
Gross Profit Growth Q
13.52%
Gross Profit Growth3 Y
96.51%
Gross Profit Growth5 Y
9.42%
Net Income
CNY 16.3M
Net Income Growth
-45.63%
Net Income Growth Q
-25.09%
Net Income Growth Years
3%
Pretax Margin
5.68%
Profit Margin
8.02%
Profit Per Employee
CNY 45,150
Profitable Years
2
ROA
2.22
Roa5y
-1.95
ROCE
9.98
ROE
7.98
Roe5y
-68.79
ROIC
4.34
Roic5y
-12.14

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr10y
-3.89%
Cagr15y
4.94%
Cagr1y
48.56%
Cagr20y
9.46%
Cagr3y
36.99%
Cagr5y
18.49%
EPS Growth
-45.64
EPS Growth Q
-25.12
EPS Growth Years
3
OCF Growth10 Y
-4.36%
Revenue Growth
-15.71x
Revenue Growth Q
-15.12x
Revenue Growth Years
0x
Revenue Growth3 Y
24.71x
Revenue Growth5 Y
1.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
CNY 0.46
Assets
CNY 464.9M
Cash
CNY 44.8M
Current Assets
CNY 256.6M
Current Liabilities
CNY 305.5M
Debt
CNY 186.4M
Debt EBITDA
CNY 4.53
Debt Equity
CNY 1.92
Debt FCF
CNY -6.64
Equity
CNY 97.1M
Interest Coverage
2.14
Liabilities
CNY 367.8M
Long Term Assets
CNY 208.3M
Long Term Liabilities
CNY 62.3M
Net Cash
CNY -141.6M
Net Cash By Market Cap
CNY -5.79
Net Debt EBITDA
CNY 4.57
Net Debt Equity
CNY 1.46
Tangible Book Value
CNY 67.2M
Tangible Book Value Per Share
CNY 0.55
WACC
4.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.84
Inventory Turnover
2.04
Net Working Capital
CNY 85.2M
Quick ratio
0.67
Working Capital
CNY -48.9M
Working Capital Turnover
CNY -3.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
-0.02%
Dividend per share
CNY 0
Last Dividend
CNY 0.17
Payout Ratio
40.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-32.75%
1Y total return
48.52%
200-day SMA
18.4
3Y total return
157.11%
50-day SMA
20.67
50-day SMA vs 200-day SMA
50over200
5Y total return
133.49%
All Time High
39.71
All Time High Change
-49.43%
All Time High Date
2016-01-11
All Time Low
2.66
All Time Low Change
656.31%
All Time Low Date
1996-08-26
ATR
0.75
Beta
0.08
Beta1y
0.04
Beta2y
0.18
Ch YTD
16
High
20.19
High52
23.44
High52 Date
2026-02-25
High52ch
-14.33%
Low
19.64
Low52
12.14
Low52 Date
2025-05-29
Low52ch
65.4%
Ma50ch
-2.84%
Price vs 200-day SMA
9.15%
RSI
51
RSI Monthly
66.59
RSI Weekly
54.79
Sharpe ratio
1.13x
Sortino ratio
1.96
Total Return
-0.02%
Tr YTD
16
Tr15y
106.16%
Tr1m
-5.06%
Tr1w
1.93%
Tr3m
1.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
CNY 15.9M
Operating Income Growth
-63.27
Operating Income Growth Q
46.68
Operating margin
7.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
44,902,638%
Net Borrowing
43,070,372
Shares Insiders
11.51%
Shares Institutions
1.37%
Shares Out
121,778,885
Shares Qo Q
0.03%
Shares Yo Y
0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
CNY -28.1M
Average Volume
2,570,412.2x
Bv Per Share
0.61
CAPEX
CNY -30.1M
Ch10y
-32.75
Ch15y
106.2
Ch1m
-5.06
Ch1w
1.93
Ch1y
48.52
Ch20y
509.2
Ch3m
1.67
Ch3y
157.1
Ch5y
133.5
Ch6m
6.75
Change
1.67%
Change From Open
1.93
Close
19.75
Days Gap
-0.25
Depreciation Amortization
15,116,932
Dollar Volume
46,900,193.4
Earnings Date
2026-04-18
EBIT
CNY 15.9M
EBITDA
CNY 31M
EPS
CNY 0.13
F Score
5
FCF
CNY -28.1M
FCF EV Yield
-1.08x
FCF Per Share
CNY -0.23
Financing CF
34,526,473
Fiscal Year End
December
Founded
1,958
Goodwill
1,614,611
Graham Number
1.3521
Graham Upside
-93.27
Income Tax
CNY 4.2M
Investing CF
-26,560,732
Is Primary Listing
1
Last Earnings Date
2026-04-18
Last Report Date
2026-03-31
Last Split Date
2006-12-15
Last Split Type
Forward
Ma150
19.1
Ma150ch
5.11%
Ma20
19.77
Ma20ch
1.56%
Net CF
9,979,682
Next Earnings Date
2026-08-28
Open
19.7
P OCF Ratio
1,214.2
Position In Range
80
Ppne
189,609,346
Price Date
2026-05-08
Price EBITDA
CNY 78.84
Ptbv Ratio
36.37
Relative Volume
0.9x
Revenue
203,848,868x
Tax By Revenue
2.06x
Tax Rate
36.3%
Tr20y
509.17%
Tr6m
6.75%
Volume
2,335,667
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SHA/600671 pay a dividend?

Capital-return profile for this ticker.

Performance

SHA/600671 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+48.5%
S&P 500 1Y: n/a
3Y total return
+157.1%
S&P 500 3Y: n/a
5Y total return
+133.5%
S&P 500 5Y: n/a
10Y total return
-32.8%
S&P 500 10Y: n/a
Ownership

Who owns SHA/600671?

Insider, institutional, and short-interest positioning.

Institutional ownership
+1.4%
Share of float held by funds and institutions
Insider ownership
+11.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

SHA/600671 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.0
Neutral momentum band
Price vs 200-day MA
+9.2%
50/200-day relationship not available
Beta (5Y)
0.08
Less volatile than the market
Sharpe ratio
1.13
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHA/600671

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600671 stock rating?

sha/600671 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600671 analysis?

The full report lives at /stocks/sha/600671/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600671?

The latest report frames sha/600671 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600671 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

sha/600671 stock profile: metrics, valuation and analysis | Agente de Mercado de Ações com IA